25 XP   0   0   10

T2 Biosystms Inc
Buy, Hold or Sell?

Let's analyse T2 Biosystms Inc together

PenkeI guess you are interested in T2 Biosystms Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of T2 Biosystms Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about T2 Biosystms Inc

I send you an email if I find something interesting about T2 Biosystms Inc.

Quick analysis of T2 Biosystms Inc (30 sec.)










What can you expect buying and holding a share of T2 Biosystms Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
2.5%

What is your share worth?

Current worth
$-5.68
Expected worth in 1 year
$-8.91
How sure are you?
30.0%

+ What do you gain per year?

Total Gains per Share
$-3.22
Return On Investment
-117.6%

For what price can you sell your share?

Current Price per Share
$2.74
Expected price per share
$0 - $3.36
How sure are you?
50%

1. Valuation of T2 Biosystms Inc (5 min.)




Live pricePrice per Share (EOD)

$2.74

Intrinsic Value Per Share

$-75.53 - $-76.48

Total Value Per Share

$-81.22 - $-82.17

2. Growth of T2 Biosystms Inc (5 min.)




Is T2 Biosystms Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$28m-$39.7m$11.8m42.3%

How much money is T2 Biosystms Inc making?

Current yearPrevious yearGrowGrow %
Making money-$10.6m-$17.8m$7.2m68.4%
Net Profit Margin-650.7%-511.2%--

How much money comes from the company's main activities?

3. Financial Health of T2 Biosystms Inc (5 min.)




4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#140 / 145

Most Revenue
#124 / 145

Most Profit
#111 / 145

Most Efficient
#130 / 145

What can you expect buying and holding a share of T2 Biosystms Inc? (5 min.)

Welcome investor! T2 Biosystms Inc's management wants to use your money to grow the business. In return you get a share of T2 Biosystms Inc.

What can you expect buying and holding a share of T2 Biosystms Inc?

First you should know what it really means to hold a share of T2 Biosystms Inc. And how you can make/lose money.

Speculation

The Price per Share of T2 Biosystms Inc is $2.74. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of T2 Biosystms Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in T2 Biosystms Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-5.68. Based on the TTM, the Book Value Change Per Share is $-0.81 per quarter. Based on the YOY, the Book Value Change Per Share is $0.68 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of T2 Biosystms Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-2.10-76.5%-2.15-78.5%-1.96-71.4%-2.41-87.9%-2.64-96.2%
Usd Book Value Change Per Share0.000.0%-0.81-29.4%0.6825.0%-0.27-9.8%-0.23-8.5%
Usd Dividend Per Share0.000.0%0.000.0%0.010.4%0.000.1%0.000.0%
Usd Total Gains Per Share0.000.0%-0.81-29.4%0.7025.4%-0.27-9.7%-0.23-8.4%
Usd Price Per Share3.00-2.39-0.54-1.32-4.74-
Price to Earnings Ratio-0.36--0.28--0.16--0.16--0.47-
Price-to-Total Gains Ratio-1.16--0.48--0.39--1.42-
Price to Book Ratio-0.53--0.42--0.13--0.99-0.16-
Price-to-Total Gains Ratio-1.16--0.48--0.39--1.42-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.74
Number of shares364
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.81-0.27
Usd Total Gains Per Share-0.81-0.27
Gains per Quarter (364 shares)-293.34-96.77
Gains per Year (364 shares)-1,173.36-387.07
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-1173-11833-390-397
20-2347-23567-781-784
30-3520-352910-1171-1171
40-4693-470214-1562-1558
50-5867-587517-1952-1945
60-7040-704820-2343-2332
70-8214-822124-2733-2719
80-9387-939427-3124-3106
90-10560-1056731-3514-3493
100-11734-1174034-3905-3880

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.040.00.00.0%0.045.01.00.0%
Book Value Change Per Share1.02.01.025.0%4.07.01.033.3%7.012.01.035.0%12.027.01.030.0%14.028.04.030.4%
Dividend per Share0.00.04.00.0%1.00.011.08.3%1.00.019.05.0%1.00.039.02.5%1.00.045.02.2%
Total Gains per Share1.02.01.025.0%4.07.01.033.3%7.012.01.035.0%12.027.01.030.0%14.028.04.030.4%

Fundamentals of T2 Biosystms Inc

About T2 Biosystms Inc

T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company also offers T2Dx Instrument, a bench-top instrument that runs various diagnostic tests from patient samples; T2Candida panel, a direct-from-blood test that identifies blood stream infections that causes sepsis and candidemia; T2Bacteria panel, a direct-from-blood test, which detects bacterial pathogens associated with sepsis; T2Resistance panel, a direct-from-blood test that identifies carbapenem resistance genes; and T2SARS-CoV-2 panel to detect SARS-CoV-2 virus. In addition, it is developing T2Biothreat panel for detection of biothreat pathogens; comprehensive sepsis panel to detect bloodstream infections caused by bacterial and Candida species, and antibiotic resistant markers; T2Cauris panel to provide direct detection of the emerging superbug Candida auris in patient skin, patient blood, and hospital environmental samples; and T2Lyme panel, a direct-from-blood test panel designed to run on the T2Dx Instrument to identify the bacteria that cause Lyme disease. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.

Fundamental data was last updated by Penke on 2024-04-12 20:39:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of T2 Biosystms Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit T2 Biosystms Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare T2 Biosystms Inc to the Diagnostics & Research industry mean.
  • A Net Profit Margin of -615.8% means that $-6.16 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of T2 Biosystms Inc:

  • The MRQ is -615.8%. The company is making a huge loss. -2
  • The TTM is -650.7%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-615.8%TTM-650.7%+34.8%
TTM-650.7%YOY-511.2%-139.5%
TTM-650.7%5Y-455.9%-194.8%
5Y-455.9%10Y-1,015.3%+559.4%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-615.8%-6.7%-609.1%
TTM-650.7%-6.7%-644.0%
YOY-511.2%0.3%-511.5%
5Y-455.9%-1.5%-454.4%
10Y-1,015.3%-3.4%-1,011.9%
1.1.2. Return on Assets

Shows how efficient T2 Biosystms Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare T2 Biosystms Inc to the Diagnostics & Research industry mean.
  • -29.7% Return on Assets means that T2 Biosystms Inc generated $-0.30 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of T2 Biosystms Inc:

  • The MRQ is -29.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -28.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-29.7%TTM-28.0%-1.7%
TTM-28.0%YOY-47.7%+19.7%
TTM-28.0%5Y-30.6%+2.6%
5Y-30.6%10Y-25.4%-5.2%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-29.7%-1.3%-28.4%
TTM-28.0%-1.3%-26.7%
YOY-47.7%-0.9%-46.8%
5Y-30.6%-0.5%-30.1%
10Y-25.4%-0.9%-24.5%
1.1.3. Return on Equity

Shows how efficient T2 Biosystms Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare T2 Biosystms Inc to the Diagnostics & Research industry mean.
  • 0.0% Return on Equity means T2 Biosystms Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of T2 Biosystms Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-15.8%+15.8%
5Y-15.8%10Y-61.9%+46.1%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ--0.5%+0.5%
TTM--0.0%
YOY-0.3%-0.3%
5Y-15.8%-1.4%-14.4%
10Y-61.9%-2.3%-59.6%

1.2. Operating Efficiency of T2 Biosystms Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient T2 Biosystms Inc is operating .

  • Measures how much profit T2 Biosystms Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare T2 Biosystms Inc to the Diagnostics & Research industry mean.
  • An Operating Margin of -555.0% means the company generated $-5.55  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of T2 Biosystms Inc:

  • The MRQ is -555.0%. The company is operating very inefficient. -2
  • The TTM is -540.0%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-555.0%TTM-540.0%-15.0%
TTM-540.0%YOY-380.5%-159.6%
TTM-540.0%5Y-387.6%-152.4%
5Y-387.6%10Y-946.3%+558.7%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-555.0%-6.2%-548.8%
TTM-540.0%0.5%-540.5%
YOY-380.5%4.0%-384.5%
5Y-387.6%3.7%-391.3%
10Y-946.3%-1.3%-945.0%
1.2.2. Operating Ratio

Measures how efficient T2 Biosystms Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 6.55 means that the operating costs are $6.55 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of T2 Biosystms Inc:

  • The MRQ is 6.550. The company is inefficient in keeping operating costs low. -1
  • The TTM is 8.131. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ6.550TTM8.131-1.580
TTM8.131YOY4.805+3.326
TTM8.1315Y5.142+2.989
5Y5.14210Y12.686-7.544
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ6.5501.280+5.270
TTM8.1311.304+6.827
YOY4.8051.236+3.569
5Y5.1421.242+3.900
10Y12.6861.205+11.481

1.3. Liquidity of T2 Biosystms Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if T2 Biosystms Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 0.45 means the company has $0.45 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of T2 Biosystms Inc:

  • The MRQ is 0.447. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.462. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.447TTM0.462-0.016
TTM0.462YOY1.855-1.393
TTM0.4625Y2.504-2.041
5Y2.50410Y4.012-1.509
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4472.111-1.664
TTM0.4622.298-1.836
YOY1.8552.599-0.744
5Y2.5043.012-0.508
10Y4.0123.081+0.931
1.3.2. Quick Ratio

Measures if T2 Biosystms Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare T2 Biosystms Inc to the Diagnostics & Research industry mean.
  • A Quick Ratio of 0.30 means the company can pay off $0.30 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of T2 Biosystms Inc:

  • The MRQ is 0.305. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.263. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.305TTM0.263+0.041
TTM0.263YOY1.261-0.998
TTM0.2635Y2.703-2.439
5Y2.70310Y4.030-1.327
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3051.204-0.899
TTM0.2631.319-1.056
YOY1.2611.602-0.341
5Y2.7031.943+0.760
10Y4.0302.203+1.827

1.4. Solvency of T2 Biosystms Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of T2 Biosystms Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare T2 Biosystms Inc to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 1.81 means that T2 Biosystms Inc assets are financed with 180.6% credit (debt) and the remaining percentage (100% - 180.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of T2 Biosystms Inc:

  • The MRQ is 1.806. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.759. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ1.806TTM1.759+0.047
TTM1.759YOY2.089-0.329
TTM1.7595Y1.512+0.247
5Y1.51210Y1.220+0.293
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8060.429+1.377
TTM1.7590.407+1.352
YOY2.0890.394+1.695
5Y1.5120.450+1.062
10Y1.2200.450+0.770
1.4.2. Debt to Equity Ratio

Measures if T2 Biosystms Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare T2 Biosystms Inc to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of T2 Biosystms Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y0.962-0.962
5Y0.96210Y2.153-1.191
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.606-0.606
TTM-0.571-0.571
YOY-0.631-0.631
5Y0.9620.658+0.304
10Y2.1530.735+1.418

2. Market Valuation of T2 Biosystms Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings T2 Biosystms Inc generates.

  • Above 15 is considered overpriced but always compare T2 Biosystms Inc to the Diagnostics & Research industry mean.
  • A PE ratio of -0.36 means the investor is paying $-0.36 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of T2 Biosystms Inc:

  • The EOD is -0.327. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.358. Based on the earnings, the company is expensive. -2
  • The TTM is -0.284. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.327MRQ-0.358+0.031
MRQ-0.358TTM-0.284-0.073
TTM-0.284YOY-0.163-0.121
TTM-0.2845Y-0.161-0.123
5Y-0.16110Y-0.472+0.311
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-0.327-0.235-0.092
MRQ-0.358-0.395+0.037
TTM-0.284-0.2840.000
YOY-0.1630.002-0.165
5Y-0.1614.834-4.995
10Y-0.4725.200-5.672
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of T2 Biosystms Inc:

  • The EOD is -0.358. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.392. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.310. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.358MRQ-0.392+0.034
MRQ-0.392TTM-0.310-0.082
TTM-0.310YOY-0.119-0.191
TTM-0.3105Y-0.174-0.135
5Y-0.17410Y-0.558+0.384
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-0.358-0.277-0.081
MRQ-0.392-0.441+0.049
TTM-0.310-1.389+1.079
YOY-0.119-2.030+1.911
5Y-0.174-1.446+1.272
10Y-0.558-1.971+1.413
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of T2 Biosystms Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of -0.53 means the investor is paying $-0.53 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of T2 Biosystms Inc:

  • The EOD is -0.482. Based on the equity, the company is expensive. -2
  • The MRQ is -0.528. Based on the equity, the company is expensive. -2
  • The TTM is -0.424. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.482MRQ-0.528+0.046
MRQ-0.528TTM-0.424-0.103
TTM-0.424YOY-0.127-0.298
TTM-0.4245Y-0.987+0.562
5Y-0.98710Y0.157-1.144
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-0.4821.897-2.379
MRQ-0.5282.222-2.750
TTM-0.4242.168-2.592
YOY-0.1273.041-3.168
5Y-0.9873.477-4.464
10Y0.1574.125-3.968
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of T2 Biosystms Inc.

3.1. Institutions holding T2 Biosystms Inc

Institutions are holding 21.545% of the shares of T2 Biosystms Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Susquehanna International Group, LLP1.11510.000155004550040
2023-12-31Vanguard Group Inc0.9264045695456950
2023-12-31BlackRock Inc0.7493036961369610
2023-12-31Geode Capital Management, LLC0.4877024054240540
2023-12-31GSA Capital Partners LLP0.41710.010920572-5224-20.2512
2023-12-31JANE STREET GROUP, LLC0.3126015417154170
2023-12-31Virtu Financial LLC0.20430.00510078100780
2023-09-30International Assets Investment Management, LLC0.00070.0001330033000
2023-12-31Group One Trading, LP0.06660.0001328432840
2023-12-31Advisor Group Holdings, Inc.0.0610300930090
2023-12-31Tower Research Capital LLC0.04130.0002203920390
2023-12-31Royal Bank of Canada0.02640130213020
2023-12-31CWM, LLC duplicate0.0063031000
2023-12-31Morgan Stanley - Brokerage Accounts0.002401201200
2023-12-31Signature Resources Capital Management, LLC0.00180.000590900
2023-12-31Wells Fargo & Co0.0004022220
2023-12-31Jjj Advisors Inc0.00020990
2023-12-31U.S. Bancorp0.00010330
2023-12-31Focused Wealth Strategies, INC.0.00010330
2023-12-31Bank of America Corp00220
Total 4.41980.0169221274+195168+88.2%

3.2. Funds holding T2 Biosystms Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-09-30BlackRock Extended Mkt Composite0.14250.00117026436956829993.9951
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.90080.00024443300
2024-02-29Fidelity Extended Market Index0.31920.000215746-76-0.4803
2024-03-31BlackRock Extended Equity Market K0.12430.0001613220.0326
2024-02-29Fidelity Total Market Index0.08250407100
2024-02-29Fidelity Series Total Market Index0.07510370600
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.05730.0003282600
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.0460.0003227040.1765
2023-12-31NT Ext Equity Mkt Idx Fd - L0.04440.00022189-1-0.0457
2023-12-31Northern Trust Extended Eq Market Idx0.04440.00022189-1-0.0457
2024-02-29Fidelity Nasdaq Composite Index0.04020.0001198300
2024-02-29Spartan Total Market Index Pool E0.03070151500
2024-02-29Vanguard U.S. Eq Idx £ Acc0.02560126200
2024-02-29Spartan Extended Market Index Pool E0.01630.00028027610.4683
2024-03-31Extended Equity Market Fund M0.01530.0001756-2-0.2639
2023-12-31BNYM Mellon SL Market Completion UC10.00530.00042602578566.6667
2023-12-31NT Ext Eq Mkt Indx Fd DC Lending Tier 50.00180.00039100
2023-12-31SSgA U.S. Extended Market Index Class I0.0004020-1-4.7619
2024-03-31State St US Extended Mkt Indx NL Cl C0.000402000
2024-02-29Fidelity U.S. Equity Index Ins Trust0.0003017170
Total 1.97280.0037792931+695957+87.8%

3.3. Insider Transactions

Insiders are holding 7.549% of the shares of T2 Biosystms Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-09-27Group L.p. CrSELL5981219
2023-09-25Group L.p. CrSELL250025
2023-09-21Group L.p. CrSELL6338230
2023-09-19Group L.p. CrSELL10401437

4. Summary

4.1. Key Performance Indicators

The key performance indicators of T2 Biosystms Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share----0.8060%0.685-100%-0.2680%-0.2320%
Book Value Per Share---5.684-5.6630%-4.934-13%-3.071-46%0.576-1086%
Current Ratio--0.4470.462-3%1.855-76%2.504-82%4.012-89%
Debt To Asset Ratio--1.8061.759+3%2.089-14%1.512+19%1.220+48%
Debt To Equity Ratio----0%-0%0.962-100%2.153-100%
Dividend Per Share----0%0.012-100%0.002-100%0.001-100%
Eps---2.096-2.152+3%-1.957-7%-2.407+15%-2.637+26%
Free Cash Flow Per Share---1.914-2.266+18%-1.577-18%-2.095+9%-2.191+14%
Free Cash Flow To Equity Per Share---1.750-0.155-91%-0.386-78%-0.279-84%-0.071-96%
Gross Profit Margin--1.0001.0000%1.0000%1.026-3%1.013-1%
Intrinsic Value_10Y_max---76.483--------
Intrinsic Value_10Y_min---75.534--------
Intrinsic Value_1Y_max---8.098--------
Intrinsic Value_1Y_min---8.616--------
Intrinsic Value_3Y_max---24.002--------
Intrinsic Value_3Y_min---25.134--------
Intrinsic Value_5Y_max---39.506--------
Intrinsic Value_5Y_min---40.700--------
Market Cap13514940.400-9%14797380.00011796594.648+25%5469498.823+171%7062546.299+110%23648311.260-37%
Net Profit Margin---6.158-6.507+6%-5.112-17%-4.559-26%-10.153+65%
Operating Margin---5.550-5.400-3%-3.805-31%-3.876-30%-9.463+71%
Operating Ratio--6.5508.131-19%4.805+36%5.142+27%12.686-48%
Pb Ratio-0.482+9%-0.528-0.424-20%-0.127-76%-0.987+87%0.157-435%
Pe Ratio-0.327+9%-0.358-0.284-21%-0.163-54%-0.161-55%-0.472+32%
Price Per Share2.740-9%3.0002.392+25%0.539+457%1.318+128%4.737-37%
Price To Free Cash Flow Ratio-0.358+9%-0.392-0.310-21%-0.119-70%-0.174-56%-0.558+42%
Quick Ratio--0.3050.263+16%1.261-76%2.703-89%4.030-92%
Return On Assets---0.297-0.280-6%-0.477+61%-0.306+3%-0.254-15%
Return On Equity----0%-0%-0.1580%-0.6190%
Total Gains Per Share----0.8060%0.697-100%-0.2660%-0.2310%
Usd Book Value---28036000.000-27932750.0000%-39760750.000+42%-18233500.000-35%1300450.000-2256%
Usd Book Value Change Per Share----0.8060%0.685-100%-0.2680%-0.2320%
Usd Book Value Per Share---5.684-5.6630%-4.934-13%-3.071-46%0.576-1086%
Usd Dividend Per Share----0%0.012-100%0.002-100%0.001-100%
Usd Eps---2.096-2.152+3%-1.957-7%-2.407+15%-2.637+26%
Usd Free Cash Flow---9442000.000-11177500.000+18%-12389500.000+31%-11257600.000+19%-11268000.000+19%
Usd Free Cash Flow Per Share---1.914-2.266+18%-1.577-18%-2.095+9%-2.191+14%
Usd Free Cash Flow To Equity Per Share---1.750-0.155-91%-0.386-78%-0.279-84%-0.071-96%
Usd Market Cap13514940.400-9%14797380.00011796594.648+25%5469498.823+171%7062546.299+110%23648311.260-37%
Usd Price Per Share2.740-9%3.0002.392+25%0.539+457%1.318+128%4.737-37%
Usd Profit---10340000.000-10613000.000+3%-17872250.000+73%-13598600.000+32%-13131625.000+27%
Usd Revenue--1679000.0001698500.000-1%4287250.000-61%4195750.000-60%2696925.000-38%
Usd Total Gains Per Share----0.8060%0.697-100%-0.2660%-0.2310%
 EOD+1 -6MRQTTM+15 -11YOY+11 -215Y+13 -1710Y+12 -18

4.2. Fundamental Score

Let's check the fundamental score of T2 Biosystms Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.327
Price to Book Ratio (EOD)Between0-1-0.482
Net Profit Margin (MRQ)Greater than0-6.158
Operating Margin (MRQ)Greater than0-5.550
Quick Ratio (MRQ)Greater than10.305
Current Ratio (MRQ)Greater than10.447
Debt to Asset Ratio (MRQ)Less than11.806
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.297
Total1/10 (10.0%)

4.3. Technical Score

Let's check the technical score of T2 Biosystms Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5036.533
Ma 20Greater thanMa 502.950
Ma 50Greater thanMa 1003.943
Ma 100Greater thanMa 2004.305
OpenGreater thanClose2.680
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets34,797
Total Liabilities62,833
Total Stockholder Equity-28,036
 As reported
Total Liabilities 62,833
Total Stockholder Equity+ -28,036
Total Assets = 34,797

Assets

Total Assets34,797
Total Current Assets25,089
Long-term Assets9,708
Total Current Assets
Cash And Cash Equivalents 15,689
Net Receivables 1,420
Inventory 4,819
Other Current Assets 3,161
Total Current Assets  (as reported)25,089
Total Current Assets  (calculated)25,089
+/-0
Long-term Assets
Property Plant Equipment 9,053
Long-term Assets Other 4
Long-term Assets  (as reported)9,708
Long-term Assets  (calculated)9,057
+/- 651

Liabilities & Shareholders' Equity

Total Current Liabilities56,152
Long-term Liabilities6,681
Total Stockholder Equity-28,036
Total Current Liabilities
Short-term Debt 42,900
Accounts payable 1,527
Other Current Liabilities 11,501
Total Current Liabilities  (as reported)56,152
Total Current Liabilities  (calculated)55,928
+/- 224
Long-term Liabilities
Long-term Liabilities  (as reported)6,681
Long-term Liabilities  (calculated)0
+/- 6,681
Total Stockholder Equity
Common Stock4
Retained Earnings -584,296
Other Stockholders Equity 556,256
Total Stockholder Equity (as reported)-28,036
Total Stockholder Equity (calculated)-28,036
+/-0
Other
Cash and Short Term Investments 15,689
Common Stock Shares Outstanding 4,058
Current Deferred Revenue224
Liabilities and Stockholders Equity 34,797
Net Debt 33,809
Net Working Capital -31,063
Short Long Term Debt Total 49,498



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-31
> Total Assets 
11,431
0
0
0
31,885
32,457
20,052
78,867
78,821
72,774
63,713
53,124
86,948
74,937
65,909
92,002
89,568
75,659
63,777
69,679
54,861
42,119
84,214
75,896
64,309
55,555
45,170
34,253
28,486
51,352
53,714
77,631
79,078
70,052
78,898
70,037
60,539
49,039
39,605
43,952
34,391
32,732
37,130
43,281
34,797
34,797
34,79734,79743,28137,13032,73234,39143,95239,60549,03960,53970,03778,89870,05279,07877,63153,71451,35228,48634,25345,17055,55564,30975,89684,21442,11954,86169,67963,77775,65989,56892,00265,90974,93786,94853,12463,71372,77478,82178,86720,05232,45731,88500011,431
   > Total Current Assets 
0
0
0
0
30,393
30,570
16,078
76,676
75,321
66,401
54,875
42,656
75,574
62,032
52,503
77,783
75,438
60,651
48,789
55,347
44,318
33,023
75,325
67,320
56,608
43,578
33,414
23,813
18,895
43,768
47,372
51,447
53,584
44,587
63,859
54,460
44,394
33,503
24,702
28,876
19,423
18,925
23,870
32,876
25,189
25,089
25,08925,18932,87623,87018,92519,42328,87624,70233,50344,39454,46063,85944,58753,58451,44747,37243,76818,89523,81333,41443,57856,60867,32075,32533,02344,31855,34748,78960,65175,43877,78352,50362,03275,57442,65654,87566,40175,32176,67616,07830,57030,3930000
       Cash And Cash Equivalents 
9,709
0
0
0
30,198
30,323
15,876
75,589
73,849
65,295
53,289
40,117
73,662
59,519
50,218
75,111
73,488
58,822
46,134
52,897
41,799
29,733
70,710
60,225
50,805
37,400
28,422
16,213
11,033
36,323
26,549
19,059
16,793
10,691
32,708
22,047
22,245
9,397
13,212
20,366
10,329
10,117
16,084
24,319
15,689
15,689
15,68915,68924,31916,08410,11710,32920,36613,2129,39722,24522,04732,70810,69116,79319,05926,54936,32311,03316,21328,42237,40050,80560,22570,71029,73341,79952,89746,13458,82273,48875,11150,21859,51973,66240,11753,28965,29573,84975,58915,87630,32330,1980009,709
       Short-term Investments 
80
0
0
0
0
0
0
0
80
80
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,247
21,990
25,396
22,617
20,080
20,042
9,996
9,989
0
0
0
0
0
0
0
0
000000009,9899,99620,04220,08022,61725,39621,9909,247000000000000000000008080000000080
       Net Receivables 
0
0
0
0
0
0
0
0
201
88
389
378
369
360
288
379
327
409
981
442
467
582
1,593
1,734
1,786
1,773
1,179
1,573
2,825
2,454
1,300
3,860
5,099
4,034
3,979
4,222
5,134
4,361
2,721
1,578
2,163
1,323
1,349
1,139
1,420
1,420
1,4201,4201,1391,3491,3232,1631,5782,7214,3615,1344,2223,9794,0345,0993,8601,3002,4542,8251,5731,1791,7731,7861,7341,5935824674429814093273792883603693783898820100000000
       Inventory 
0
0
0
0
0
0
0
0
115
252
569
1,057
683
1,259
1,435
1,338
803
489
1,014
1,254
1,344
2,082
2,158
3,337
2,677
2,664
3,100
4,110
3,599
3,275
4,111
3,569
3,636
4,525
4,784
4,822
3,909
5,172
5,673
4,242
4,349
4,936
4,337
4,281
4,819
4,819
4,8194,8194,2814,3374,9364,3494,2425,6735,1723,9094,8224,7844,5253,6363,5694,1113,2753,5994,1103,1002,6642,6773,3372,1582,0821,3441,2541,0144898031,3381,4351,2596831,05756925211500000000
   > Long-term Assets 
0
0
0
0
1,492
1,887
3,974
2,191
3,500
6,373
8,838
10,468
11,374
12,905
13,406
14,219
14,130
15,008
14,988
14,332
10,543
9,096
8,889
8,576
7,701
11,977
11,756
10,440
9,591
7,584
6,342
26,184
25,494
25,465
15,039
15,577
16,145
15,536
14,903
15,076
14,968
13,807
13,260
10,405
9,608
9,708
9,7089,60810,40513,26013,80714,96815,07614,90315,53616,14515,57715,03925,46525,49426,1846,3427,5849,59110,44011,75611,9777,7018,5768,8899,09610,54314,33214,98815,00814,13014,21913,40612,90511,37410,4688,8386,3733,5002,1913,9741,8871,4920000
       Property Plant Equipment 
1,195
0
0
0
1,118
1,237
1,327
1,698
2,760
5,332
7,809
9,448
10,655
12,287
12,815
13,628
13,589
14,468
14,510
13,854
10,015
8,710
8,503
8,190
7,315
11,591
11,370
10,054
9,205
7,198
5,976
5,314
14,805
14,808
14,410
13,865
14,441
14,250
13,616
13,792
13,274
13,221
12,660
9,789
9,053
9,053
9,0539,0539,78912,66013,22113,27413,79213,61614,25014,44113,86514,41014,80814,8055,3145,9767,1989,20510,05411,37011,5917,3158,1908,5038,71010,01513,85414,51014,46813,58913,62812,81512,28710,6559,4487,8095,3322,7601,6981,3271,2371,1180001,195
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20,186
10,002
10,002
0
0
0
0
0
0
0
0
0
0
0
0
00000000000010,00210,00220,1860000000000000000000000000000000
       Long-term Assets Other 
0
0
0
0
374
650
2,647
493
427
728
716
707
719
618
591
591
541
540
478
478
528
386
386
386
386
386
386
386
386
386
366
684
687
655
629
1,712
1,704
1,286
1,287
1,284
1,694
586
49
65
555
4
455565495861,6941,2841,2871,2861,7041,7126296556876843663863863863863863863863863865284784785405415915916187197077167284274932,6476503740000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
313
313
313
313
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000031331331331300000000
> Total Liabilities 
7,952
0
0
0
121,428
14,752
127,031
17,437
25,820
29,294
29,661
29,314
40,009
39,848
43,250
41,420
50,230
49,629
51,452
51,552
53,521
52,206
52,231
52,134
52,922
57,135
60,790
60,165
62,491
59,049
58,102
60,057
70,352
70,618
69,889
72,500
73,442
74,690
77,124
75,621
74,360
82,618
73,553
62,517
62,833
62,833
62,83362,83362,51773,55382,61874,36075,62177,12474,69073,44272,50069,88970,61870,35260,05758,10259,04962,49160,16560,79057,13552,92252,13452,23152,20653,52151,55251,45249,62950,23041,42043,25039,84840,00929,31429,66129,29425,82017,437127,03114,752121,4280007,952
   > Total Current Liabilities 
2,129
0
0
0
4,046
3,717
6,746
6,662
4,859
7,455
7,690
8,454
12,275
14,723
17,482
18,536
9,885
8,913
10,468
10,245
51,782
50,922
10,315
9,401
52,297
53,735
57,799
57,698
60,572
57,667
7,949
10,351
9,800
10,401
9,345
11,398
11,688
12,673
13,192
10,943
10,506
17,829
66,056
55,455
56,152
56,152
56,15256,15255,45566,05617,82910,50610,94313,19212,67311,68811,3989,34510,4019,80010,3517,94957,66760,57257,69857,79953,73552,2979,40110,31550,92251,78210,24510,4688,9139,88518,53617,48214,72312,2758,4547,6907,4554,8596,6626,7463,7174,0460002,129
       Short-term Debt 
0
0
0
0
1,759
280
1,769
290
295
514
564
1,658
4,739
7,219
10,915
11,788
1,570
1,565
1,613
1,663
40,942
41,554
4,028
3,661
42,641
42,450
42,885
44,171
42,902
43,400
2,010
1,941
1,151
1,168
1,168
1,171
1,174
1,195
1,217
1,295
1,352
1,415
52,051
42,454
0
42,900
42,900042,45452,0511,4151,3521,2951,2171,1951,1741,1711,1681,1681,1511,9412,01043,40042,90244,17142,88542,45042,6413,6614,02841,55440,9421,6631,6131,5651,57011,78810,9157,2194,7391,6585645142952901,7692801,7590000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
295
0
0
0
4,449
0
10,631
11,495
1,269
1,316
1,365
1,416
42,934
43,399
3,771
3,399
44,515
42,450
42,885
42,258
42,902
43,400
0
0
0
0
0
0
0
0
0
0
0
0
50,571
40,907
41,284
0
041,28440,90750,57100000000000043,40042,90242,25842,88542,45044,5153,3993,77143,39942,9341,4161,3651,3161,26911,49510,63104,44900029500000000
       Accounts payable 
571
0
0
0
943
1,035
720
725
735
1,173
1,562
993
1,228
1,552
795
895
962
1,161
1,660
993
648
779
1,152
551
744
618
2,911
3,427
3,753
1,686
1,779
2,407
2,058
3,907
2,890
2,616
2,832
3,385
5,231
2,063
1,296
3,131
2,234
1,088
1,527
1,527
1,5271,5271,0882,2343,1311,2962,0635,2313,3852,8322,6162,8903,9072,0582,4071,7791,6863,7533,4272,9116187445511,1527796489931,6601,1619628957951,5521,2289931,5621,1737357257201,035943000571
       Other Current Liabilities 
738
0
0
0
1,344
2,402
4,257
5,647
3,749
3,739
3,788
4,604
4,162
4,216
4,506
5,036
4,908
4,060
4,701
5,513
8,456
7,702
4,210
4,427
8,215
10,009
11,326
9,490
13,632
12,343
3,961
5,713
6,361
4,926
4,849
6,998
7,164
7,755
7,819
7,422
7,686
13,134
11,506
11,637
1,789
11,501
11,5011,78911,63711,50613,1347,6867,4227,8197,7557,1646,9984,8494,9266,3615,7133,96112,34313,6329,49011,32610,0098,2154,4274,2107,7028,4565,5134,7014,0604,9085,0364,5064,2164,1624,6043,7883,7393,7495,6474,2572,4021,344000738
   > Long-term Liabilities 
0
0
0
0
117,382
11,035
120,285
10,775
20,961
21,839
21,971
20,860
27,734
25,125
25,768
22,884
40,345
40,716
40,984
41,307
1,739
1,284
41,916
42,733
625
3,400
2,991
2,467
1,919
1,382
50,153
49,706
60,552
60,217
60,544
61,102
61,754
62,017
63,932
64,678
63,854
64,789
7,497
7,062
6,681
6,681
6,6816,6817,0627,49764,78963,85464,67863,93262,01761,75461,10260,54460,21760,55249,70650,1531,3821,9192,4672,9913,40062542,73341,9161,2841,73941,30740,98440,71640,34522,88425,76825,12527,73420,86021,97121,83920,96110,775120,28511,035117,3820000
       Long term Debt Total 
0
0
0
0
0
0
2,411
10,733
20,660
20,592
20,522
19,344
26,222
23,572
24,168
21,246
39,504
39,750
39,908
40,089
1,008
609
38,344
38,869
0
0
0
0
0
0
44,000
44,612
45,235
45,855
46,487
47,132
0
0
0
0
0
0
0
0
0
0
000000000047,13246,48745,85545,23544,61244,00000000038,86938,3446091,00840,08939,90839,75039,50421,24624,16823,57226,22219,34420,52220,59220,66010,7332,411000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
-1,759
-280
-1,769
-290
-295
-514
-564
-1,658
-4,739
-7,219
-10,915
-11,788
-1,570
-1,565
-1,613
-1,663
-40,942
-41,554
-4,028
-3,661
-42,641
-37,291
-38,148
-39,868
-39,046
-40,017
924
479
9,382
9,087
9,964
9,665
8,185
9,060
8,748
8,569
8,214
7,832
-43,138
-33,885
8,214
-42,900
-42,9008,214-33,885-43,1387,8328,2148,5698,7489,0608,1859,6659,9649,0879,382479924-40,017-39,046-39,868-38,148-37,291-42,641-3,661-4,028-41,554-40,942-1,663-1,613-1,565-1,570-11,788-10,915-7,219-4,739-1,658-564-514-295-290-1,769-280-1,7590000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
313
313
313
313
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000031331331331300000000
       Warrants
0
0
0
0
0
0
117,851
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000117,851000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
24
195
252
313
380
436
546
665
774
49
175
305
467
0
0
962
1,157
0
0
0
0
0
0
2,821
3,080
3,350
3,645
3,947
4,255
4,577
4,653
4,709
4,791
4,849
4,917
0
0
0
0
00004,9174,8494,7914,7094,6534,5774,2553,9473,6453,3503,0802,8210000001,1579620046730517549774665546436380313252195240000000
       Deferred Long Term Liability 
0
0
0
0
0
0
23
18
106
995
1,136
1,136
1,076
1,007
935
864
792
791
771
751
731
675
2,610
2,616
492
0
0
0
0
0
2,391
1,235
100
181
0
0
0
0
0
0
0
0
0
0
0
0
0000000000001811001,2352,391000004922,6162,6106757317517717917928649351,0071,0761,1361,1369951061823000000
> Total Stockholder Equity
3,479
0
0
0
-89,543
17,705
-106,979
61,430
53,001
43,480
34,052
23,810
46,939
35,089
22,659
50,582
39,338
26,030
12,325
18,127
1,340
-10,087
31,983
23,762
11,387
-1,580
-15,620
-25,912
-34,005
-7,697
-4,388
17,574
8,726
-566
9,009
-2,463
-12,903
-25,651
-37,519
-31,669
-39,969
-49,886
-36,423
-19,236
-28,036
-28,036
-28,036-28,036-19,236-36,423-49,886-39,969-31,669-37,519-25,651-12,903-2,4639,009-5668,72617,574-4,388-7,697-34,005-25,912-15,620-1,58011,38723,76231,983-10,0871,34018,12712,32526,03039,33850,58222,65935,08946,93923,81034,05243,48053,00161,430-106,97917,705-89,5430003,479
   Common Stock
1
0
0
0
1
14
1
20
20
20
20
20
24
24
24
30
30
31
32
36
36
36
43
44
44
44
44
45
49
119
128
147
147
148
165
166
166
171
198
7
8
21
242
4
0
4
40424221871981711661661651481471471281194945444444444336363632313030242424202020202011410001
   Retained Earnings Total Equity0000000000-460,072-446,110-433,635-422,975-413,066-401,811-391,126-376,177-362,136-347,965-332,318-317,171-302,022-291,255-278,930-266,117-247,923-233,848-218,392-203,689-189,140-176,357-162,311-148,885-136,853-125,209-114,213-103,595-94,519-106,980000000
   Accumulated Other Comprehensive Income 
0
0
0
0
-2,651
-2,795
-234,499
-78,867
-3,342
-3,595
-3,942
-4,321
-4,807
-5,317
-5,854
-6,426
-7,066
-7,728
-7,783
-8,475
-9,124
-9,752
-10,220
-10,727
-11,307
-11,843
-12,333
-12,799
-13,236
-13,688
-14,028
-36
9
16
4
4
-4
-11
0
0
0
0
0
0
0
0
00000000-11-444169-36-14,028-13,688-13,236-12,799-12,333-11,843-11,307-10,727-10,220-9,752-9,124-8,475-7,783-7,728-7,066-6,426-5,854-5,317-4,807-4,321-3,942-3,595-3,342-78,867-234,499-2,795-2,6510000
   Capital Surplus 
0
0
0
0
0
0
0
155,929
156,576
157,673
159,241
160,643
195,800
197,376
198,992
239,692
242,997
244,391
246,141
266,014
267,421
268,807
323,195
325,740
328,514
330,694
332,301
336,179
342,121
383,310
397,295
430,529
431,544
432,905
454,950
457,439
0
0
0
0
0
0
0
0
0
0
0000000000457,439454,950432,905431,544430,529397,295383,310342,121336,179332,301330,694328,514325,740323,195268,807267,421266,014246,141244,391242,997239,692198,992197,376195,800160,643159,241157,673156,576155,9290000000
   Treasury Stock0000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
2,651
99,651
117,874
155,929
159,918
161,268
163,183
164,964
200,607
202,693
204,846
246,118
250,063
252,119
253,924
274,489
276,545
278,559
333,415
336,467
339,821
342,537
344,634
348,978
355,357
396,998
411,323
430,529
431,545
432,905
454,950
457,439
459,151
462,900
469,028
492,444
494,556
502,277
521,866
554,716
0
556,256
556,2560554,716521,866502,277494,556492,444469,028462,900459,151457,439454,950432,905431,545430,529411,323396,998355,357348,978344,634342,537339,821336,467333,415278,559276,545274,489253,924252,119250,063246,118204,846202,693200,607164,964163,183161,268159,918155,929117,87499,6512,6510000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue7,193
Cost of Revenue-16,022
Gross Profit-8,829-8,829
 
Operating Income (+$)
Gross Profit-8,829
Operating Expense-38,324
Operating Income-47,153-47,153
 
Operating Expense (+$)
Research Development13,494
Selling General Administrative26,129
Selling And Marketing Expenses0
Operating Expense38,32439,623
 
Net Interest Income (+$)
Interest Income0
Interest Expense-5,343
Other Finance Cost-359
Net Interest Income-5,702
 
Pretax Income (+$)
Operating Income-47,153
Net Interest Income-5,702
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-50,077-44,229
EBIT - interestExpense = -52,496
-50,077
-44,734
Interest Expense5,343
Earnings Before Interest and Taxes (EBIT)-47,153-44,734
Earnings Before Interest and Taxes (EBITDA)-46,294
 
After tax Income (+$)
Income Before Tax-50,077
Tax Provision-0
Net Income From Continuing Ops-49,836-50,077
Net Income-50,077
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses54,346
Total Other Income/Expenses Net-2,9245,702
 

Technical Analysis of T2 Biosystms Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of T2 Biosystms Inc. The general trend of T2 Biosystms Inc is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine T2 Biosystms Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of T2 Biosystms Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 2.75 < 2.75 < 3.36.

The bearish price targets are: .

Tweet this
T2 Biosystms Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of T2 Biosystms Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

T2 Biosystms Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of T2 Biosystms Inc. The current macd is -0.25153122.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the T2 Biosystms Inc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for T2 Biosystms Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the T2 Biosystms Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
T2 Biosystms Inc Daily Moving Average Convergence/Divergence (MACD) ChartT2 Biosystms Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of T2 Biosystms Inc. The current adx is 18.82.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy T2 Biosystms Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
T2 Biosystms Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of T2 Biosystms Inc. The current sar is 3.384.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
T2 Biosystms Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of T2 Biosystms Inc. The current rsi is 36.53. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
T2 Biosystms Inc Daily Relative Strength Index (RSI) ChartT2 Biosystms Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of T2 Biosystms Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the T2 Biosystms Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
T2 Biosystms Inc Daily Stochastic Oscillator ChartT2 Biosystms Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of T2 Biosystms Inc. The current cci is -133.27953057.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
T2 Biosystms Inc Daily Commodity Channel Index (CCI) ChartT2 Biosystms Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of T2 Biosystms Inc. The current cmo is -27.34579303.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
T2 Biosystms Inc Daily Chande Momentum Oscillator (CMO) ChartT2 Biosystms Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of T2 Biosystms Inc. The current willr is -82.5.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
T2 Biosystms Inc Daily Williams %R ChartT2 Biosystms Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of T2 Biosystms Inc.

T2 Biosystms Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of T2 Biosystms Inc. The current atr is 0.3482685.

T2 Biosystms Inc Daily Average True Range (ATR) ChartT2 Biosystms Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of T2 Biosystms Inc. The current obv is 14,595,422.

T2 Biosystms Inc Daily On-Balance Volume (OBV) ChartT2 Biosystms Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of T2 Biosystms Inc. The current mfi is 75.93.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
T2 Biosystms Inc Daily Money Flow Index (MFI) ChartT2 Biosystms Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for T2 Biosystms Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-02ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-10WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-12BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-04MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

T2 Biosystms Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of T2 Biosystms Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5036.533
Ma 20Greater thanMa 502.950
Ma 50Greater thanMa 1003.943
Ma 100Greater thanMa 2004.305
OpenGreater thanClose2.680
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of T2 Biosystms Inc with someone you think should read this too:
  • Are you bullish or bearish on T2 Biosystms Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about T2 Biosystms Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about T2 Biosystms Inc

I send you an email if I find something interesting about T2 Biosystms Inc.


Comments

How you think about this?

Leave a comment

Stay informed about T2 Biosystms Inc.

Receive notifications about T2 Biosystms Inc in your mailbox!